©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Nephrol. Mar 25, 2024; 13(1): 89637
Published online Mar 25, 2024. doi: 10.5527/wjn.v13.i1.89637
Published online Mar 25, 2024. doi: 10.5527/wjn.v13.i1.89637
Renoprotective strategies
Vaia D Raikou, Department of Nephrology, Doctors’General Clinic, Athens 11257, Greece
Author contributions: Raikou VD contributed tostudy design, data collection, manuscript preparation, literature search.
Conflict-of-interest statement: All the author declares no conflict of interests.
Corresponding author: Vaia D Raikou, PhD, Chief Doctor, Department of Nephrology, Doctors’ General Clinic, 26 Kefallinias, Athens 11257, Greece. vraikou@med.uoa.gr
Received: November 7, 2023
Peer-review started: November 7, 2023
First decision: November 30, 2023
Revised: December 1, 2023
Accepted: December 26, 2023
Article in press: December 26, 2023
Published online: March 25, 2024
Processing time: 135 Days and 10.1 Hours
Peer-review started: November 7, 2023
First decision: November 30, 2023
Revised: December 1, 2023
Accepted: December 26, 2023
Article in press: December 26, 2023
Published online: March 25, 2024
Processing time: 135 Days and 10.1 Hours
Core Tip
Core Tip: Renoprotection presents a wide field of approaches, including a strict control of blood pressure, diabetes mellitus management and a balanced nutritional therapy. New diagnostic measures using isolated cells on bedside and novel therapeutic strategies are developed in terms the renoprotection and reducing of kidney disease progression resulting in a decreased cardiovascular risk for morbidity and/or mortality in chronic kidney disease patients.